Navigation Links
Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board
Date:10/11/2007

OXFORD, England, October 11 /PRNewswire/ -- Oxford Genome Sciences (UK) Ltd "OGeS" announces today that it has further strengthened its Scientific Advisory Board (SAB) with the appointment of Sir Walter Bodmer, currently Head of the Cancer and Immunogenetics Laboratory in the Weatherall Institute of Molecular Medicine at the University of Oxford, which is actively researching the fundamental genetic and biological changes which lead to the development of colorectal cancer.

In addition to the SAB appointment, OGeS and Sir Walter's laboratory will collaborate on the evaluation of OGeS cancer drug development candidates in the area of colorectal cancer.

Prior to taking up his current position, Sir Walter Bodmer was the Director General of the Imperial Cancer Research Fund, London, a position he assumed after having been the Fund's Director of Research for 12 years. Before joining the Imperial Cancer Research Fund, he was the Professor of Genetics at the University of Oxford. Dr Bodmer moved to Oxford University from Stanford University where he was a Professor in the Department of Genetics.

Dr Bodmer, who has developed models for population genetics, worked extensively on the HLA system and the use of somatic cell hybrids for human linkage studies, received his Ph.D. in Genetics in 1959 from the University of Cambridge. He became a fellow of the Royal Society in 1974, a foreign member of the US national Academy of Sciences in 1981 and was knighted in 1986 for his contributions to science.

Dr Christian Rohlff, CEO of OGeS commenting on today's announcement said:

"I am delighted that someone of Walter's scientific standing has agreed to join our Scientific Advisory Board. I am sure his broad ranging experience in genetics and biology and his current work in the field of colorectal cancer will allow him to make an important contribution to OGeS as we continue to further develop our position in the exciting field of personalised medicin
'/>"/>

SOURCE Oxford Genome Sciences
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Chemical-petroleum executive joins Virent Energy board
2. Schneider National exec joins TrafficCast board
3. Doyle joins governors in support of stem cell bill
4. Genomics researcher Hood joins NimbleGen board
5. Fergus joins Baird Venture Partners, Caden Bio
6. Meier joins Broadlook Technologies as COO
7. Prodesse joins forces with Invitrogen
8. Wisconsin joins price-fixing suit vs. D-RAM makers
9. Napier joins board of Third Wave Technologies
10. Schmidt rejoins Renaissance Learning
11. Tommy Thompson joins drug company as advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014 Research and Markets ... Size Analysis Market 2014-2018" report to their offering. ... size analysis is a technique used to determine the size ... liquid. It is crucial to analyze the size of particles ... particle size analysis is performed to determine the behavior and ...
(Date:7/26/2014)... Canada Endoscopy Visualization Systems Market ... the Canada Endoscopy Visualization Systems market. The report ... (in units) and average prices (in US dollars) ... Mid-Range Endoscopy Visualization Systems and Low-End Endoscopy Visualization ... . , The report also provides company shares ...
(Date:7/25/2014)... , July 25, 2014 Amgen (NASDAQ: ... today declared a $0.61 per share dividend for the ... on Sept. 5, 2014, to all stockholders of record ... 2014.  About Amgen Amgen is committed ... from serious illnesses by discovering, developing, manufacturing and delivering ...
(Date:7/25/2014)... from the University of Leicester has furthered our ... potential to create new materials using nanosized ,building ... in the prestigious academic journal Physical Review ... examine in rich detail the structure and internal ... acetylene molecule and a single helium atom. , ...
Breaking Biology Technology:Global Particle Size Analysis Market 2014-2018 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3
... revenue increase as broad corporate changes are ... ... Nanotech, Inc. (OTC,Bulletin Board: AVNA) today reported financial results for its ... fiscal,period since the Company refocused its business model from managing the,development ...
... 16 Immunosyn,Corporation (OTC Bulletin Board: IMYN), a ... and distribution rights to,the biopharmaceutical SF-1019 from its ... the quarter ending March 31, 2008., For ... incurred $175,632.00,in general and administrative expenses and $13,393.00 ...
... in the ... ... BSX ) today announced U.S. Food and Drug Administration,(FDA) approval of ... defibrillators (CRT-D) and cardiac,resynchronization therapy pacemakers (CRT-P), both of which treat ...
Cached Biology Technology:Advance Nanotech Reports First Quarter 2008 Financial Results 2Advance Nanotech Reports First Quarter 2008 Financial Results 3Advance Nanotech Reports First Quarter 2008 Financial Results 4Advance Nanotech Reports First Quarter 2008 Financial Results 5Advance Nanotech Reports First Quarter 2008 Financial Results 6Advance Nanotech Reports First Quarter 2008 Financial Results 7Advance Nanotech Reports First Quarter 2008 Financial Results 8Advance Nanotech Reports First Quarter 2008 Financial Results 9Advance Nanotech Reports First Quarter 2008 Financial Results 10Immunosyn Corporation Files 10-Q 2Immunosyn Corporation Files 10-Q 3Boston Scientific Announces FDA Approval of New Heart Failure Lead 2Boston Scientific Announces FDA Approval of New Heart Failure Lead 3Boston Scientific Announces FDA Approval of New Heart Failure Lead 4
(Date:7/27/2014)... date, researchers from the U.K. provide national, regional, and ... (HCV). Findings published in Hepatology, a journal of the ... that genotype 1 is the most prevalent worldwide, with ... in East Asia. Genotype 3, at just over 54 ... genotypes 2, 4, 6, and 5. , Despite ...
(Date:7/27/2014)... Microorganisms like bacteria and fungi can evade treatment by ... antifungal drugs. These permanent mutations were once thought to ... Now a new study has shown that microorganisms can ... as epimutations -- to gain the benefits of drug ... was discovered in a fungus called Mucor circinelloides, it ...
(Date:7/27/2014)... scientists at Barts Cancer Institute have found that targeting ... significantly more effective, according to research published in ... Institute, part of Queen Mary University of London, have ... signals the body to repair itself after chemotherapy or ... the researchers removed FAK from blood vessels that grew ...
Breaking Biology News(10 mins):Hepatitis C virus genotype 1 is most prevalent worldwide 2Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3New drug target can break down cancer's barrier against treatment 2
... threat, city and country birds do not react in the ... a new study, urban birds have changed their anti-predator behaviour ... with a predator, its only objective is to escape. However, ... their countryside counterparts, despite being from the same species. Urbanisation ...
... backbone of our modern economy. Nearly every aspect of life ... it is not just the lights that go out. In ... working. Even telephones, radios and televisions become paralyzed. If the ... gas and fuel and the functioning of respirators at intensive ...
... advances in the new and developing field of restoration ... deltas from an array of threats, Indiana University Bloomington ... Nature Geoscience . The commentary, published this week ... is disappearing from river deltas at alarming rates. And ...
Cached Biology News:City birds adapt to their new predators 2Dealing with power outages more efficiently 2Geologist calls for advances in restoration sedimentology 2
... active ingredient in Molecular Probes. SlowFadeAntifade ... to act as a free radical ... Our original SlowFade formulation (S-2828) was ... of fluorescein to almost zero (Figure ...
b6-2A12...
... in this kit are prepared with pure ... Biochains Mitochondria Isolation Kit is designed to ... fast and easy way. One kit is ... isolations (enriching mitochondria from 10 20 ...
... The Freedom EVOlyzer is Tecans new ... automated microplate processing. Freedom EVOlyzer is a ... includes state-of-the art reader, washer and incubation ... software. The Freedom EVOlyzer is available in ...
Biology Products: